These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
76 related articles for article (PubMed ID: 11443014)
1. The burden of the Himalayan porter. Basnyat B; Schepens B High Alt Med Biol; 2001; 2(2):315-6. PubMed ID: 11443014 [No Abstract] [Full Text] [Related]
2. Another night at the Himalayan Rescue Association Aid Post in Pheriche, Nepal: the porter who fell 300 m. Martindale MR High Alt Med Biol; 2007; 8(3):253-5. PubMed ID: 17824826 [No Abstract] [Full Text] [Related]
3. Pugh's report on the British Himalayan expedition to Cho Oyu in 1952. Cotes JE High Alt Med Biol; 2007; 8(2):164-6. PubMed ID: 17584011 [No Abstract] [Full Text] [Related]
4. Who should not go high? West JB High Alt Med Biol; 2009; 10(1):1-2. PubMed ID: 19278346 [No Abstract] [Full Text] [Related]
5. Is it safe to visit high places? Gherardin T Aust Fam Physician; 1999 Feb; 28(2):156. PubMed ID: 10048255 [No Abstract] [Full Text] [Related]
6. Awareness of altitude sickness among a sample of trekkers in Nepal. Glazer JL; Edgar C; Siegel MS Wilderness Environ Med; 2005; 16(3):132-8. PubMed ID: 16209468 [TBL] [Abstract][Full Text] [Related]
7. [Trekking from the medical viewpoint. Health risks and preventive measures exemplified by Nepal tourism]. Klinsing U Fortschr Med; 1987 Apr; 105(13):245-7. PubMed ID: 3596440 [No Abstract] [Full Text] [Related]
8. Height of Mt. Everest: physiological and medical implications. West JB High Alt Med Biol; 2006; 7(1):1-2. PubMed ID: 16544959 [No Abstract] [Full Text] [Related]
9. Medical problems of porters and trekkers in the Nepal Himalaya. Basnyat B; Litch JA Wilderness Environ Med; 1997 May; 8(2):78-81. PubMed ID: 11990146 [TBL] [Abstract][Full Text] [Related]
10. Acute mountain sickness prophylaxis: knowledge, attitudes, & behaviours in the Everest region of Nepal. Kilner T; Mukerji S Travel Med Infect Dis; 2010 Nov; 8(6):395-400. PubMed ID: 21112541 [TBL] [Abstract][Full Text] [Related]
11. [Trekking and altitude complications. Faulty behavior of trekking tourists--disease picture--first-aid in the Himalayas]. Miketta G; Deumling C Fortschr Med; 1987 Apr; 105(13):62-3. PubMed ID: 3596445 [No Abstract] [Full Text] [Related]
12. A comparison of the incidence and understanding of altitude illness between porters and trekkers in the Solu Khumbu Region of Nepal. Newcomb L; Sherpa C; Nickol A; Windsor J Wilderness Environ Med; 2011 Sep; 22(3):197-201. PubMed ID: 21962045 [TBL] [Abstract][Full Text] [Related]
13. Difficult decisions at altitude: the management of an acutely dyspneic porter at 5000 meters. Bellis F; Parris R; Thake D; Richards P Wilderness Environ Med; 2005; 16(4):212-8. PubMed ID: 16366203 [TBL] [Abstract][Full Text] [Related]
15. A Season at the Himalayan Rescue Association Aid Post in Manang. Timilsina S; Hillwood GE; Thwaites GE; Thwaites CL; Bhandari T Wilderness Environ Med; 2024 Sep; 35(3):308-313. PubMed ID: 39095053 [TBL] [Abstract][Full Text] [Related]
16. Descriptive report of experience designing and staffing the first-ever medical clinic at Mt. Everest base camp, 2003. Freer L High Alt Med Biol; 2004; 5(1):89-90. PubMed ID: 15072722 [No Abstract] [Full Text] [Related]
17. Low-dose acetylsalicylic Acid analog and acetazolamide for prevention of acute mountain sickness. Basnyat B; Gertsch JH; Holck PC High Alt Med Biol; 2008; 9(4):349; author reply 351-2. PubMed ID: 19115924 [No Abstract] [Full Text] [Related]
18. Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT). Gertsch JH; Basnyat B; Johnson EW; Onopa J; Holck PS BMJ; 2004 Apr; 328(7443):797. PubMed ID: 15070635 [TBL] [Abstract][Full Text] [Related]